Ameren Corp. (AEE) Financials Nov 14, 2014, 5:19
Ameren Corp. (AEE) Financials Nov 14, 2014, 5:19 p.m.
Income Statement Balance Sheet Cash Flow Statement
Annual Financials for Ameren Corp.
Fiscal year is January-December. All values USD millions. 2009 2010 2011 2012 2013 5-year trend
Sales/Revenue 7.21B 7.64B 7.54B 6.81B 5.84B
Cost of Goods Sold (COGS) incl. D&A 5.32B 5.69B 5.71B 5B 4.2B
COGS excluding D&A 4.52B 4.86B 4.9B 4.14B 3.42B
Depreciation & Amortization Expense 801M 837M 808M 858M 777M
Depreciation 724M 762M 741M 775M -
Amortization of Intangibles 53M 54M 61M 83M -
Gross Income 1.89B 1.95B 1.83B 1.81B 1.64B
2009 2010 2011 2012 2013 5-year trend
SG&A Expense - - - 0 0
Research & Development - - - 0 0
Other SG&A - - - 0 0
Other Operating Expense 412M 449M 457M 468M 458M
Unusual Expense (39M) 571M 136M 2.59B (1M)
EBIT after Unusual Expense 39M (571M) (136M) (2.59B) 1M
Non Operating Income/Expense (83M) 10M 19M 11M 13M
Non-Operating Interest Income 30M 33M 32M 33M 30M
Equity in Affiliates (Pretax) 0 0 - 0 -
Interest Expense 508M 497M 451M 447M 398M
Gross Interest Expense 508M 497M 451M 447M 398M
Interest Capitalized 0 0 0 0 0
Pretax Income 956M 476M 836M (1.65B) 829M
Income Tax 332M 325M 310M (680M) 311M
Income Tax - Current Domestic (79M) 15M (39M) 34M (99M)
Income Tax - Current Foreign - - - - -
Income Tax - Deferred Domestic 411M 310M 349M (707M) 416M
Income Tax - Deferred Foreign - - - - -
Income Tax Credits 0 0 - 7M 6M
Equity in Affiliates 0 0 - 0 -
Other After Tax Income (Expense) 0 0 0 0 0
Consolidated Net Income 624M 151M 526M (974M) 518M
Minority Interest Expense 12M 12M 7M 0 6M
Net Income 612M 139M 519M (974M) 512M
Extraordinaries & Discontinued Operations 0 0 0 0 (223M)
Extra Items & Gain/Loss Sale Of Assets 0 0 0 0 0
Cumulative Effect - Accounting Chg 0 0 0 0 0
Discontinued Operations 0 0 0 0 (223M)
Net Income After Extraordinaries 612M 139M 519M (974M) 289M
Preferred Dividends 0 0 0 0 0
Net Income Available to Common 612M 139M 519M (974M) 512M
EPS (Basic) 2.78 0.58 2.15 (4.01) 1.19
Basic Shares Outstanding 220.4M 238.8M 241.5M 242.6M 242.6M
EPS (Diluted) 2.78 0.58 2.15 (4.01) 1.18
Diluted Shares Outstanding 220.4M 238.8M 241.5M 242.6M 244.5M
EBITDA 2.28B 2.34B 2.18B 2.2B 1.96B
Copyright 2014 FactSet Research Systems Inc. All rights reserved. Source FactSet Fundamentals.
Scroll down for more posts ▼
Top 10 Most Recent News Articles
New Horizons for Developers Today, if you're building an app, you're just as likely to be wrangling with legal regulations as you are writing code. That's where k-ID’s new SDK, Kai, comes into play—it's not just another tool in the shed, it’s the whole toolbox for dealing with age-specific app requirements everywhere. The Changing App Landscape Why does this matter?...
Continue Reading
Uncovering Surprising Market Overlaps Ever thought the guy barreling through mud in his rugged 4x4 might have more in common with an electric vehicle enthusiast than we'd usually guess? That's the curveball Qloo and Kearney are tossing at us. Their latest study shakes up the tired old assumptions floating around the automotive sector about who's buying what and why. Using...
Continue Reading
Changing the Food Hall Game Innovation isn't just a Silicon Valley buzzword; it found its place at the Central Park St. Pete Food Hall in Florida. These guys have figured out the magic formula to streamline multi-vendor dining with Epson's point-of-sale label printers. We're talking about keeping guests from playing musical chairs with food orders, folks. It's a...
Continue Reading
Securities Fraud Allegations Hit Beta Bionics Here's a fresh one on the market front—Beta Bionics is in hot water, and it's not looking pretty. The ticker NASDAQ:BBNX is swirling in the chaos of a class action lawsuit, thanks to a stock tumble that would make even seasoned traders cringe. What's got investors riled up? The nitty-gritty centers on accusations that the...
Continue Reading
Co-Diagnostics Gears Up for Indian TB Test Market Picture this: Co-Diagnostics, a molecular diagnostics player, is on the brink of a significant leap toward expanding its footprint in India with its TB test. The stage is set, with a clinical study already turning in results as solid as old boots. We're talking sensitivity hovering around 97.3% and specificity at...
Continue Reading
A New Spin in Madera Cue the fanfare, folks! The North Fork Mono Casino just threw open its doors earlier than expected today, marking a hefty $750 million wager right in the heart of California's Central Valley. It's a big deal managed by Station Casinos, part of Red Rock Resorts, Inc. (NASDAQ: RRR)—teaming up with the North Fork Rancheria of Mono Indians for a...
Continue Reading
Ensign's Legal Storm: Investors on Edge Man, you can't ignore the weighty allegations pounding on Ensign Group's door right now. The skilled nursing giant, under the ticker NASDAQ:ENSG, is feeling the heat from a securities class action filed against them, and my gut tells me this isn't going to blow over quietly. This case sure looks like a financial tempest that could...
Continue Reading
Billd's Bold Move Across America Forget piecemeal rollouts; Billd's taking their latest brainchild, Flex Line, right into the heart of America's subcontractor landscape. This isn't some flash-in-the-pan financial offering, either—it's a heavy-hitter poised to shake up the way subcontractors wrangle their working capital. We're talking about a line of credit that's as...
Continue Reading
Phenomenal Financial Benchmark You gotta give it to SK hynix. They've just blown past that 100 trillion won ceiling like it's a minor bump on the highway. For folks tracking big numbers in memory semiconductors, this is fireworks-worthy. We're talking 104.6155 trillion won in revenue, a solid 83.3338 trillion won in operating profit, and a 39.7756 trillion won net profit....
Continue Reading
Unpacking Johnson Controls' Fiscal 2026 Performance You know, it's not often that a company hits a home run with back-to-back quarters, but Johnson Controls (NYSE:JCI) seems to be swinging for the fences as they wrap up fiscal 2026. What we've got here is a robust set of financial results, showcasing not just growth but momentum that's got investors humming. We're talking...
Continue Reading
Top 5 Most Recently Viewed Articles
US National Debt Surges Past $38 Trillion As the federal government encounters a shutdown, the U.S. gross national debt has topped $38 trillion, according to the latest Treasury data, causing widespread concern over the country's financial health. Rapid Escalation of Debt Since 2000 This increase in debt represents the fastest rise outside the COVID-19 pandemic period....
Continue Reading
Guardian Metal Resources Excels in Tungsten Discovery Guardian Metal Resources plc (LON:GMET, OTCQX:GMTLF) is making waves in the mineral exploration world with impressive tungsten assay results from its Pilot Mountain project. Based in Nevada, this company specializes in uncovering valuable mineral resources, and their latest findings showcase not only their commitment...
Continue Reading
West Cancer Center Introduces Innovative Holographic Consultations West Cancer Center & Research Institute has teamed up with Proto Inc. to launch an exciting new initiative: the first-ever holographic consultations between doctors and patients. This groundbreaking achievement was unveiled at a prominent event at UC Berkeley, which centered on Global Healthcare...
Continue Reading
PJT Partners Hits All-Time High Stock Price PJT Partners Inc. has reached the impressive milestone of a stock price soaring to an all-time high of $137.24. This remarkable achievement exhibits the confidence investors have in this global advisory-focused investment bank. Over the past year, PJT Partners has experienced an extraordinary 75.12% increase in its stock value,...
Continue Reading
Wyndham Hotels & Resorts Welcomes New Addition to Board Wyndham Hotels & Resorts, a prominent name in the hospitality industry, recently announced the exciting appointment of Alexandra A. Jung to its Board of Directors. This decision highlights the company's commitment to enhancing its governance and operational effectiveness. About Alexandra A. Jung Alexandra A. Jung...
Continue Reading